发明名称 FUMARIC ACID AMIDES
摘要 The invention relates to the use of fumaric acid amides of general formula (1) wherein R1 represents OR3 or a D- or L- amino acid radical NH-CHR4-COOH bound by an amide bond, wherein R3 is hydrogen, a straight-chained or branched, optionally substituted C1-24-alkyl radical, phenyl radical or a C6-10 aralkyl radical and R4 is a sidechain of a natural or synthetic amino acid, and R2 represents a D- or L- amino acid radical bound by an amide bond NH-CHR5 COOH or a peptide radical bound by an amide bond having 2-100 amino acids, wherein R5 is a side chain of a natural or synthetic amino acid, in the production of a medicament (1) for therapy of an auto-immune disease, (2) for use in transplantation medicine, (3) for therapy of mitochondrial diseases, selected from the group consisting of Parkinson syndrome, Alzheimer's disease, Huntingdon's chorea disease, retinopathia pigmentosa or mitochondrial encephalomypathy and (4) for therapy of NfkappaB mediated diseases.
申请公布号 WO02055063(A3) 申请公布日期 2003.10.09
申请号 WO2002EP00107 申请日期 2002.01.08
申请人 FUMAPHARM AG;JOSHI, RAJENDRA, KUMAR;STREBEL, HANS-PETER 发明人 JOSHI, RAJENDRA, KUMAR;STREBEL, HANS-PETER
分类号 A61K38/00;A61K31/00;A61K31/16;A61K31/194;A61K31/198;A61K31/225;A61P1/00;A61P1/04;A61P1/16;A61P3/10;A61P9/00;A61P9/14;A61P11/00;A61P13/12;A61P17/00;A61P19/02;A61P19/06;A61P25/00;A61P25/14;A61P25/16;A61P25/28;A61P31/00;A61P31/04;A61P31/12;A61P35/00;A61P37/02;C07C235/76;C07K14/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址